Outcomes of radical nephroureterectomy: A series from the upper tract urothelial carcinoma collaboration

Cancer

Volumn 115, Issue 6, 2009, Pages 1224-1233

  Margulis, Vitaly ^a   Shariat, Shahrokh F ^b   Matin, Surena F ^a   Kamat, Ashish M ^a   Zigeuner, Richard ^c   Kikuchi, Eiji ^d   Lotan, Yair ^b   Weizer, Alon ^e   Raman, Jay D ^f   Wood, Christopher G ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c UNIVERSITY OF GRAZ   (Austria)

^d KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f Department of Obstetrics Gynecology   (United States)

Author keywords

Prognostic factors; Radical nephroureterectomy; Transitional cell carcinoma; Urothelial carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CARCINOMA IN SITU; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY NECROSIS; KIDNEY PELVIS; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; NEPHROURETERECTOMY; OUTCOME ASSESSMENT; PATHOLOGIST; PRIORITY JOURNAL; UROGENITAL TRACT CANCER;

AGED; CARCINOMA, TRANSITIONAL CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MULTICENTER STUDIES AS TOPIC; NEOPLASM RECURRENCE, LOCAL; NEPHRECTOMY; PROGNOSIS; TREATMENT OUTCOME; URETER; URETERAL NEOPLASMS; UROLOGIC NEOPLASMS;

EID: 63449104039     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24135     Document Type: Article

References (27)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43-66.
2. Munoz JJ, Ellison LM. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol. 2000;164:1523-1525.
3. Hall MC, Womack S, Sagalowsky AI, Carmody T, Erick- stad MD, Roehrborn CG. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology. 1998;52:594-601.
4. Langner C, Hutterer G, Chromecki T, Winkelmayer I, Rehak P, Zigeuner R. pT classification, grade, and vascular invasion as prognostic indicators in urothelial carcinoma of the upper urinary tract. Mod Pathol. 2006;19:272-279.
5. Novara G, De Marco V, Gottardo F, et al. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers. Cancer. 2007;110:1715-1722.
6. Secin FP, Koppie TM, Salamanca JI, et al. Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer. Int J Urol. 2007;14:26-32.
7. Brown GA, Busby JE, Wood CG, et al. Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: time to change the treatment paradigm? BJU Int. 2006;98:1176-1180.
8. Hong B, Park S, Hong JH, Kim CS, Ro JY, Ahn H. Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract. Urology. 2005;65:692-696.
9. Kikuchi E, Horiguchi Y, Nakashima J, et al. Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract. J Urol. 2005;174:2120-2123; discussion 2124.
10. Langner C, Hutterer G, Chromecki T, Leibl S, Rehak P, Zigeuner R. Tumor necrosis as prognostic indicator in transitional cell carcinoma of the upper urinary tract. J Urol. 2006;176:910-913; discussion 913-914.
11. Langner C, Hutterer G, Chromecki T, Rehak P, Zigeuner R. Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract. Virchows Arch. 2006;448:604-611.
12. Wu CF, Pang ST, Chen CS, Chuang CK, Chen Y, Lin PY. The impact factors on prognosis of patients with pT3 upper urinary tract transitional cell carcinoma. J Urol. 2007;178:446-450; discussion 450.
13. Park S, Hong B, Kim CS, Ahn H. The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract. JUrol. 2004;171(pt 1):621-625.
14. Akdogan B, Dogan HS, Eskicorapci SY, Sahin A, Erkan I, Ozen H. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma. J Urol. 2006;176:48-52.
15. Catto JW, Yates DR, Rehman I, et al. Behavior of urothelial carcinoma with respect to anatomical location. J Urol. 2007;177:1715-1720.
16. Greene FL, Page DL, Fleming ID, et al. American Joint Committee on Cancer (AJCC) Staging Manual. 6th ed. Philadelphia: Springer; 2002.
17. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol. 1998;22:1435-1448.
18. Jimenez RE, Gheiler E, Oskanian P, et al. Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival. Am J Surg Pathol. 2000;24:980-987.
19. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515-519.
20. Olgac S, Mazumdar M, Dalbagni G, Reuter VE. Urothelial carcinoma of the renal pelvis: a clinicopathologic study of 130 cases. Am J Surg Pathol. 2004;28:1545-1552.
21. Holmang S, Johansson SL. Urothelial carcinoma of the upper urinary tract: comparison between the WHO/ISUP 1998 consensus classification and WHO 1999 classification system. Urology. 2005;66:274-278.
22. Kondo T, Nakazawa H, Ito F, Hashimoto Y, Toma H, Tanabe K. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract. J Urol. 2007;178(pt 1):1212- 1217; discussion 1217.
23. Hasui Y, Nishi S, Kitada S, Osada Y, Asada Y. The prognostic significance of vascular invasion in upper urinary tract transitional cell carcinoma. J Urol. 1992;148:1783-1785.
24. Miyata Y, Kanda S, Ohba K, et al. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D. Clin Cancer Res. 2006;12(pt 1):800-806.
25. Quek ML, Stein JP, Nichols PW, et al. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy. J Urol. 2005;174:103- 106.
26. Lotan Y, Gupta A, Shariat SF, et al. Lymphovascular invasion is independently associated with overall survival, cause- specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol. 2005;23:6533-6539.
27. Kruger S, Noack F, Bohle A, Feller AC. Histologic tumor growth pattern is significantly associated with disease-related survival in muscle-invasive transitional cell carcinoma of the urinary bladder. Oncol Rep. 2004;12:609-613.